Michael Gibney

Michael Gibney
Michael
Gibney
Production Editor

Michael is the production editor with FierceMarkets' Life Sciences group. He also writes for FierceDrugDelivery and FierceMedicalDevices. A graduate of the University of Missouri's School of Journalism, Michael has worked as an editor for Patch.com in Connecticut and a writer for the Bozeman Daily Chronicle in Montana. Michael lives in Washington, DC, and enjoys hiking, running and exploring the city's bookstores and movie theaters. He can be reached at [email protected]

Stories by Michael Gibney

Nasdaq screens

FDA delivery-based withdrawal has Lannett, Mallinckrodt flailing

Generics of Johnson & Johnson’s ADHD pill Concerta are hitting hard times due to an FDA crackdown on their bioequivalence. The agency said six months ago that generics makers Lannett and Mallinckrodt had that much time to confirm their extended-release technology matched that of J&J’s.
C-dots

Nanoparticles alone form 'wave of destruction' against cancer cells

Cornell Professor Ulrich Wiesner’s C-dots are showing more and more that they could be the next big step in nanotech drug delivery. In their latest incarnation, the diagnostic and delivery combination particles have shown that they can alone deprive cancer cells of nutrients, resulting in their death.